Patient safety

A cross-section of the heart as part of a virtual twin. Photo courtesy of Dassault Systèmes

Advances in the use of virtual twins in clinical trials

This follows an ongoing five-year study by Dassault Systèmes in collaboration with the FDA. Virtual twins, which accurately simulate specific aspects of patient populations, allow for the refinement, reduction and elimination of human and animal participation